COSCIENS Biopharma Inc. Lease And Sublease Payments Recognised As Expense
COSCIENS Biopharma Inc. (CSCIF) reported Lease And Sublease Payments Recognised As Expense of $344.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense · last filed 2019-04-01
| Period end | Lease And Sublease Payments Recognised As Expense 12 month |
|---|---|
| 2018-12-31 | $344.00K 20-F · filed 2019-04-01 |
| 2017-12-31 | $2.25M 20-F · filed 2019-04-01 |
| 2016-12-31 | $1.13M 20-F · filed 2019-04-01 |
| 2015-12-31 | $1.45M 20-F · filed 2018-03-28 |